Fast, Expert and Open – how the MHRA is poised to become a global leader in risk-proportionate regulation

List of Field Safety Notices from 13 to 17 October 2025.

Using the Integrated Scientific Advice service from the Medicines and Healthcare products Regulatory Agency (MHRA) and National Institute for Health and Care Excellence (NICE).

A story of hope, medical innovation, and the impact of effective regulation on access to treatment.

There is a risk of patient harm arising through medication error during a transition period where the original and new formulation of Rybelsus ® tablets, with different stated mg dose but similar bioavailability, will both be available on the market.

List of Field Safety Notices from 29 December 2025 to 2 January 2026.

International collaboration establishes new quality standards to improve reliability of gut health studies – improving accuracy to provide better diagnosis and treatment.